Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between vendor pathways and individual EMRs.